Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study

Sh. Erdes, V. I. Mazurov, I. Z. Gaydukova, O. N. Anoshenkova, I. B. Vinogradova, Yu. Yu. Grabovetskaya, S. Y. Davidian, N. A. Kiryukhina, O. E. Epifanova, L. V. Masneva, L. V. Menshikova, O. N. Mironenko, N. E. Nikulenkova, T. V. Povarova, A. N. Poliatika, R. R. Samigullina, A. E. Sizikov, I. N. Totrov, I. F. Umnova, J. V. Usacheva, A. L. Chudinov

Open source

DOI
10.1134/s1607672924701084
Published
2024-08-28
Container
Doklady Biochemistry and Biophysics
Publisher
Pleiades Publishing Ltd
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1134/s1607672924701084,
  title = {Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study},
  author = {Sh. Erdes and V. I. Mazurov and I. Z. Gaydukova and O. N. Anoshenkova and I. B. Vinogradova and Yu. Yu. Grabovetskaya and S. Y. Davidian and N. A. Kiryukhina and O. E. Epifanova and L. V. Masneva and L. V. Menshikova and O. N. Mironenko and N. E. Nikulenkova and T. V. Povarova and A. N. Poliatika and R. R. Samigullina and A. E. Sizikov and I. N. Totrov and I. F. Umnova and J. V. Usacheva and A. L. Chudinov},
  year = {2024},
  journal = {Doklady Biochemistry and Biophysics},
  doi = {10.1134/s1607672924701084},
  url = {https://doi.org/10.1134/s1607672924701084}
}

RIS

TY  - JOUR
TI  - Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study
AU  - Sh. Erdes
AU  - V. I. Mazurov
AU  - I. Z. Gaydukova
AU  - O. N. Anoshenkova
AU  - I. B. Vinogradova
AU  - Yu. Yu. Grabovetskaya
AU  - S. Y. Davidian
AU  - N. A. Kiryukhina
AU  - O. E. Epifanova
AU  - L. V. Masneva
AU  - L. V. Menshikova
AU  - O. N. Mironenko
AU  - N. E. Nikulenkova
AU  - T. V. Povarova
AU  - A. N. Poliatika
AU  - R. R. Samigullina
AU  - A. E. Sizikov
AU  - I. N. Totrov
AU  - I. F. Umnova
AU  - J. V. Usacheva
AU  - A. L. Chudinov
PY  - 2024
JO  - Doklady Biochemistry and Biophysics
DO  - 10.1134/s1607672924701084
UR  - https://doi.org/10.1134/s1607672924701084
ER  - 

APA

Erdes, S., Mazurov, V. I., Gaydukova, I. Z., Anoshenkova, O. N., Vinogradova, I. B., Grabovetskaya, Y. Y., Davidian, S. Y., Kiryukhina, N. A., Epifanova, O. E., Masneva, L. V., Menshikova, L. V., Mironenko, O. N., Nikulenkova, N. E., Povarova, T. V., Poliatika, A. N., Samigullina, R. R., Sizikov, A. E., Totrov, I. N., Umnova, I. F., Usacheva, J. V., & Chudinov, A. L. (2024). Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study. Doklady Biochemistry and Biophysics. https://doi.org/10.1134/s1607672924701084

Source records